Wednesday, September 6, 2017

Supernus Pharmaceuticals - Chart of the Day

Supernus Pharmaceutical (SUPN) is the Barchart Chart of the Day.  The specialty drug company has a Trend Spotter buy signal, a Weighted Alpha of 125.40+ and gained 111.13% in the last year.

The Chart of the Day belongs to Supernus Pharmceutical (SUPN).  I found the specialty drug stock by using Barchart to sort today's All Time High list first by the highest Weighted Alpha, then again by technical buy signals of 80% or more.  Since the Trend Spotter signaled another buy in 8/16 the stock gained 2.96%.

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.


The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 14.13% in he last month
  • Relative Strength Index 61.22%
  • Technical support level at 46.45
  • Recently traded at 46.60 with a 50 day moving average of 43.22
Fundamental factors:
  • Market Cap $2.39 billion
  • P/E 41.58
  • Revenue expected to grow 37.50% this year and another 29.40% next year
  • Earnings estimated to increase 59.60% next year and compound at an annual rate of 29.00% for the next 5 years
  • Wall Street analysts issued 5 strong buy and 2 hold recommendations on the stock


No comments:

Post a Comment